/generation of primary fibroblast cell lines
Ended Purchase Order Awarded
- Contract number
- HHSN268201300130P
- Awardee
-
Terveyden JA Hyvinvoinnin Laitos UEI J38JJCJ3M641
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $34,091
Award facts
- Opportunity
-
- NHLBICSBHG2013153DLM Solicitation number
- Generation of Primary Fibroblast Cell Lines in Finland Award Notice · Posted May 3, 2013
- Contract value 100% obligated
- $34,091.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN268201300130P?
HHSN268201300130P was awarded to Terveyden JA Hyvinvoinnin Laitos by National Heart Lung and Blood Institute (National Institutes of Health) on May 14, 2013.
How much is contract HHSN268201300130P worth?
The government has obligated $34,091 on HHSN268201300130P.
Was contract HHSN268201300130P competed?
The extent of competition for HHSN268201300130P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award